Literature DB >> 24569967

[How does type of health insurance affect receipt of Pap testing in Peru?].

Leslie Barrionuevo-Rosas1, Laia Palència2, Carme Borrell3.   

Abstract

OBJECTIVE: Describe the association between receipt of cervical cytology and type of health insurance in Peruvian women, and determine the role of sociodemographic and sexual health variables in this relationship.
METHODS: A cross-sectional study using information on a sample of 12 272 women aged 30 to 49 years from the Demographic and Family Health Survey (ENDES), Peru, 2005-2008. The dependent variable was receipt of at least one Pap smear in the last five years. The primary independent variables were type of health insurance, educational level, household socioeconomic level, ethnicity, and place of residence. Prevalence ratio, obtained from Poisson regression with robust variance, was used to measure multivariate association.
RESULTS: Among sexually active women, 62.7% had received at least one Pap test in the last five years. Percentage of women tested varied by type of health insurance. Women with public or private insurance had a greater probability of having received a Pap smear--1.27 (95% CI, 1.24-1.31) and 1.52 (95% CI, 1.46-1.58) times greater, respectively--than uninsured women. This association was primarily explained by socioeconomic status variables. In addition, women who participated the least in screening were characterized by illiteracy or only a primary education, low socioeconomic level, speaking an indigenous language, and living in a rural area. When they also lacked health insurance, the gap widened, rising to as much as one third compared to more advantaged social groups.
CONCLUSIONS: Inequalities were found in receipt of Pap testing according to type of health insurance; women without insurance were least likely to be screened, implying existence of a barrier to cervical cancer screening in Peru.

Entities:  

Mesh:

Year:  2013        PMID: 24569967

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  10 in total

1.  Inequities in cervical cancer care in indigenous Peruvian women.

Authors:  Paul E Nevin; Patricia J Garcia; Magaly M Blas; Deepa Rao; Yamilé Molina
Journal:  Lancet Glob Health       Date:  2019-05       Impact factor: 26.763

2.  Social network characteristics and cervical cancer screening among Quechua women in Andean Peru.

Authors:  John S Luque; Samuel Opoku; Daron G Ferris; Wendy S Guevara Condorhuaman
Journal:  BMC Public Health       Date:  2016-02-24       Impact factor: 3.295

3.  Cytological screening for cervical cancer and associated factors in the penitentiary population of Peru.

Authors:  J C Ruiz-Maza; R A Soto-Azpilcueta; J Sanchez-Salvatierra; Y Torres-Prado
Journal:  Rev Esp Sanid Penit       Date:  2018 Sep-Dec

4.  Socioeconomic determinants of cancer screening utilisation in Latin America: A systematic review.

Authors:  Bernardo Nuche-Berenguer; Dikaios Sakellariou
Journal:  PLoS One       Date:  2019-11-25       Impact factor: 3.240

5.  Cervical cancer mortality in Peru: regional trend analysis from 2008-2017.

Authors:  J Smith Torres-Roman; Luz Ronceros-Cardenas; Bryan Valcarcel; Miguel A Arce-Huamani; Janina Bazalar-Palacios; Jorge Ybaseta-Medina; Carlo La Vecchia; Christian S Alvarez
Journal:  BMC Public Health       Date:  2021-01-26       Impact factor: 3.295

6.  Cervical cancer screening programme attendance and compliance predictors regarding Colombia's Amazon region.

Authors:  Alejandra González; Ricardo Sánchez; Milena Camargo; Sara Cecilia Soto-De León; Luisa Del Río-Ospina; Luis Hernando Mora; Edwin Ramírez; Anny Alejandra Rodríguez; Paula Hurtado; Manuel Elkin Patarroyo; Manuel Alfonso Patarroyo
Journal:  PLoS One       Date:  2022-01-25       Impact factor: 3.240

Review 7.  Policy Considerations to Promote Equitable Cervical Cancer Screening and Treatment in Peru.

Authors:  Andrea Thoumi; Sarah J Bond; Mary Elizabeth Dotson; Marlee Krieger; Patricia J Garcia; Nirmala Ramanujam
Journal:  Ann Glob Health       Date:  2021-11-24       Impact factor: 2.462

8.  Cost of community-based human papillomavirus self-sampling in Peru: A micro-costing study.

Authors:  Michelle B Shin; Patricia J Garcia; Enrique M Saldarriaga; José L Fiestas; Kristjana H Ásbjörnsdóttir; Sarah J Iribarren; Ruanne V Barnabas; Sarah Gimbel
Journal:  Lancet Reg Health Am       Date:  2021-12-29

9.  Women's Participation in Pap Smear Screening in a Developing Country: Evidence for Improving Health Systems.

Authors:  Carolina Santamaría-Ulloa; Ileana Quirós-Rojas; Melina Montero-López; Hazel Quesada-Leitón
Journal:  Front Oncol       Date:  2021-06-15       Impact factor: 6.244

10.  Control of cervical cancer in Peru: Current barriers and challenges for the future.

Authors:  Alfredo Aguilar; Joseph A Pinto; Jhajaira Araujo; Williams Fajardo; Leny Bravo; Luis Pinillos; Carlos Vallejos
Journal:  Mol Clin Oncol       Date:  2016-06-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.